News on Pierre Fabre from BioPortfolio.com http://www.BioPortfolio.com Consolidated Pierre Fabre news from BioPortfolio.com Wed, 10 Feb 2010 03:11:36 GMT en Pierre Fabre signs license and development agreement with Abbott Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022676&HITNO=0&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022676&THISHREF=http://c.moreover.com/click/here.pl%3fz2527794663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022676&HITNO=0&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022676&THISHREF=http://c.moreover.com/click/here.pl%3fz2527794663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Abbott Enters Into Cancer Research Collaboration With Pierre Fabrehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021642&HITNO=1&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021642&THISHREF=http://c.moreover.com/click/here.pl%3fz2527294574%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021642&HITNO=1&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021642&THISHREF=http://c.moreover.com/click/here.pl%3fz2527294574%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: Abbott Enters Into Cancer Research Collaboration With Pierre Fabrehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021641&HITNO=2&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021641&THISHREF=http://c.moreover.com/click/here.pl%3fz2527294527%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021641&HITNO=2&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021641&THISHREF=http://c.moreover.com/click/here.pl%3fz2527294527%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: Pierre Fabre signs license and development agreement with Abbott ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022773&HITNO=3&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022773&THISHREF=http://c.moreover.com/click/here.pl%3fz2527852785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022773&HITNO=3&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022773&THISHREF=http://c.moreover.com/click/here.pl%3fz2527852785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: French Pierre Fabre invests in cancer treatment researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010000&HITNO=4&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010000&THISHREF=http://c.moreover.com/click/here.pl%3fz2522195480%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010000&HITNO=4&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010000&THISHREF=http://c.moreover.com/click/here.pl%3fz2522195480%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001922&HITNO=5&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001922&THISHREF=http://c.moreover.com/click/here.pl%3fz2518625893%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001922&HITNO=5&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001922&THISHREF=http://c.moreover.com/click/here.pl%3fz2518625893%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Abbott, Pierre Fabre Enter Cancer R&D Pacthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002227&HITNO=6&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002227&THISHREF=http://c.moreover.com/click/here.pl%3fz2518788983%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002227&HITNO=6&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002227&THISHREF=http://c.moreover.com/click/here.pl%3fz2518788983%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comContract Pharma: Week of Feb. 1, 2010: Company and People Notes: Cephalon Buys Mepha; BASi's CEO Retires; and More.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008042&HITNO=7&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008042&THISHREF=http://c.moreover.com/click/here.pl%3fz2521396302%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008042&HITNO=7&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008042&THISHREF=http://c.moreover.com/click/here.pl%3fz2521396302%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Week Of Feb. 1, 2010: Company And People Notes: Cephalon Buys Mepha AG; BASi's CEO Retires; And More.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003107&HITNO=8&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003107&THISHREF=http://c.moreover.com/click/here.pl%3fz2519287801%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003107&HITNO=8&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003107&THISHREF=http://c.moreover.com/click/here.pl%3fz2519287801%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Abbott, Pierre Fabre form R&D collaboration to explore next-generation cMet antibodieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002850&HITNO=9&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002850&THISHREF=http://c.moreover.com/click/here.pl%3fz2519197561%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002850&HITNO=9&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002850&THISHREF=http://c.moreover.com/click/here.pl%3fz2519197561%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999981&HITNO=10&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999981&THISHREF=http://c.moreover.com/click/here.pl%3fz2517760255%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999981&HITNO=10&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999981&THISHREF=http://c.moreover.com/click/here.pl%3fz2517760255%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Abbott And Pierre Fabre SA Announce Collaboration To Research And Develop Novel Treatments For Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997784&HITNO=11&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997784&THISHREF=http://c.moreover.com/click/here.pl%3fz2516850955%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997784&HITNO=11&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997784&THISHREF=http://c.moreover.com/click/here.pl%3fz2516850955%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999170&HITNO=12&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999170&THISHREF=http://c.moreover.com/click/here.pl%3fz2517345866%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999170&HITNO=12&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999170&THISHREF=http://c.moreover.com/click/here.pl%3fz2517345866%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Abbott And Pierre Fabre SA Announce Collaboration To Research And Develop Novel Treatments For Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995977&HITNO=13&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995977&THISHREF=http://c.moreover.com/click/here.pl%3fz2516016268%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995977&HITNO=13&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995977&THISHREF=http://c.moreover.com/click/here.pl%3fz2516016268%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995934&HITNO=14&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995934&THISHREF=http://c.moreover.com/click/here.pl%3fz2515991303%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995934&HITNO=14&MSIZE=90&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pierre%20Fabre&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995934&THISHREF=http://c.moreover.com/click/here.pl%3fz2515991303%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: